Request for Covid-19 Impact Assessment of this Report
The United States Duck Virus Enteritis Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Duck Virus Enteritis Vaccine market, reaching US$ million by the year 2028. As for the Europe Duck Virus Enteritis Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Duck Virus Enteritis Vaccine players cover Ceva Santé Animale, Chengdu TECBOND Biological, Institute of Animal Health and Veterinary Biologicals, and Institute of Veterinary Preventive Medicine, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Duck Virus Enteritis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live Vaccines
Killed Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Duck
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Duck Virus Enteritis Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Duck Virus Enteritis Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Duck Virus Enteritis Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Duck Virus Enteritis Vaccine Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Duck Virus Enteritis Vaccine Sales by Type
2.3.1 Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Duck Virus Enteritis Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Duck Virus Enteritis Vaccine Sale Price by Type (2017-2022)
2.4 Duck Virus Enteritis Vaccine Segment by Application
2.4.1 Duck
2.4.2 Others
2.5 Duck Virus Enteritis Vaccine Sales by Application
2.5.1 Global Duck Virus Enteritis Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Duck Virus Enteritis Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Duck Virus Enteritis Vaccine Sale Price by Application (2017-2022)
3 Global Duck Virus Enteritis Vaccine by Company
3.1 Global Duck Virus Enteritis Vaccine Breakdown Data by Company
3.1.1 Global Duck Virus Enteritis Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Duck Virus Enteritis Vaccine Revenue by Company (2020-2022)
3.2.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Duck Virus Enteritis Vaccine Sale Price by Company
3.4 Key Manufacturers Duck Virus Enteritis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Duck Virus Enteritis Vaccine Product Location Distribution
3.4.2 Players Duck Virus Enteritis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Duck Virus Enteritis Vaccine by Geographic Region
4.1 World Historic Duck Virus Enteritis Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Duck Virus Enteritis Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Geographic Region
4.2 World Historic Duck Virus Enteritis Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Duck Virus Enteritis Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Country/Region
4.3 Americas Duck Virus Enteritis Vaccine Sales Growth
4.4 APAC Duck Virus Enteritis Vaccine Sales Growth
4.5 Europe Duck Virus Enteritis Vaccine Sales Growth
4.6 Middle East & Africa Duck Virus Enteritis Vaccine Sales Growth
5 Americas
5.1 Americas Duck Virus Enteritis Vaccine Sales by Country
5.1.1 Americas Duck Virus Enteritis Vaccine Sales by Country (2017-2022)
5.1.2 Americas Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)
5.2 Americas Duck Virus Enteritis Vaccine Sales by Type
5.3 Americas Duck Virus Enteritis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Duck Virus Enteritis Vaccine Sales by Region
6.1.1 APAC Duck Virus Enteritis Vaccine Sales by Region (2017-2022)
6.1.2 APAC Duck Virus Enteritis Vaccine Revenue by Region (2017-2022)
6.2 APAC Duck Virus Enteritis Vaccine Sales by Type
6.3 APAC Duck Virus Enteritis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Duck Virus Enteritis Vaccine by Country
7.1.1 Europe Duck Virus Enteritis Vaccine Sales by Country (2017-2022)
7.1.2 Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)
7.2 Europe Duck Virus Enteritis Vaccine Sales by Type
7.3 Europe Duck Virus Enteritis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Duck Virus Enteritis Vaccine by Country
8.1.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type
8.3 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Duck Virus Enteritis Vaccine
10.3 Manufacturing Process Analysis of Duck Virus Enteritis Vaccine
10.4 Industry Chain Structure of Duck Virus Enteritis Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Duck Virus Enteritis Vaccine Distributors
11.3 Duck Virus Enteritis Vaccine Customer
12 World Forecast Review for Duck Virus Enteritis Vaccine by Geographic Region
12.1 Global Duck Virus Enteritis Vaccine Market Size Forecast by Region
12.1.1 Global Duck Virus Enteritis Vaccine Forecast by Region (2023-2028)
12.1.2 Global Duck Virus Enteritis Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Duck Virus Enteritis Vaccine Forecast by Type
12.7 Global Duck Virus Enteritis Vaccine Forecast by Application
13 Key Players Analysis
13.1 Ceva Santé Animale
13.1.1 Ceva Santé Animale Company Information
13.1.2 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offered
13.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ceva Santé Animale Main Business Overview
13.1.5 Ceva Santé Animale Latest Developments
13.2 Chengdu TECBOND Biological
13.2.1 Chengdu TECBOND Biological Company Information
13.2.2 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offered
13.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Chengdu TECBOND Biological Main Business Overview
13.2.5 Chengdu TECBOND Biological Latest Developments
13.3 Institute of Animal Health and Veterinary Biologicals
13.3.1 Institute of Animal Health and Veterinary Biologicals Company Information
13.3.2 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offered
13.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Institute of Animal Health and Veterinary Biologicals Main Business Overview
13.3.5 Institute of Animal Health and Veterinary Biologicals Latest Developments
13.4 Institute of Veterinary Preventive Medicine
13.4.1 Institute of Veterinary Preventive Medicine Company Information
13.4.2 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offered
13.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Institute of Veterinary Preventive Medicine Main Business Overview
13.4.5 Institute of Veterinary Preventive Medicine Latest Developments
13.5 International Duck Research Cooperative
13.5.1 International Duck Research Cooperative Company Information
13.5.2 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offered
13.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 International Duck Research Cooperative Main Business Overview
13.5.5 International Duck Research Cooperative Latest Developments
13.6 MSD Animal Health (Merck)
13.6.1 MSD Animal Health (Merck) Company Information
13.6.2 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offered
13.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 MSD Animal Health (Merck) Main Business Overview
13.6.5 MSD Animal Health (Merck) Latest Developments
13.7 Ringpu (Tianjin)Bio-Pharmacy
13.7.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
13.7.2 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offered
13.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ringpu (Tianjin)Bio-Pharmacy Main Business Overview
13.7.5 Ringpu (Tianjin)Bio-Pharmacy Latest Developments
13.8 Veterinary Research Institute
13.8.1 Veterinary Research Institute Company Information
13.8.2 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offered
13.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Veterinary Research Institute Main Business Overview
13.8.5 Veterinary Research Institute Latest Developments
14 Research Findings and Conclusion
Table 1. Duck Virus Enteritis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Duck Virus Enteritis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Duck Virus Enteritis Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Duck Virus Enteritis Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Duck Virus Enteritis Vaccine Revenue by Application (2017-2022)
Table 13. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Duck Virus Enteritis Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Duck Virus Enteritis Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Duck Virus Enteritis Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Duck Virus Enteritis Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Duck Virus Enteritis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Duck Virus Enteritis Vaccine Products Offered
Table 22. Duck Virus Enteritis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Duck Virus Enteritis Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Duck Virus Enteritis Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Duck Virus Enteritis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Duck Virus Enteritis Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Duck Virus Enteritis Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Duck Virus Enteritis Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Duck Virus Enteritis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Duck Virus Enteritis Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Duck Virus Enteritis Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Duck Virus Enteritis Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Duck Virus Enteritis Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Duck Virus Enteritis Vaccine
Table 66. Key Market Challenges & Risks of Duck Virus Enteritis Vaccine
Table 67. Key Industry Trends of Duck Virus Enteritis Vaccine
Table 68. Duck Virus Enteritis Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Duck Virus Enteritis Vaccine Distributors List
Table 71. Duck Virus Enteritis Vaccine Customer List
Table 72. Global Duck Virus Enteritis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Duck Virus Enteritis Vaccine Sales Market Forecast by Region
Table 74. Global Duck Virus Enteritis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Duck Virus Enteritis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Duck Virus Enteritis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Duck Virus Enteritis Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Duck Virus Enteritis Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Duck Virus Enteritis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Duck Virus Enteritis Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Duck Virus Enteritis Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Duck Virus Enteritis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Ceva Santé Animale Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offered
Table 94. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Ceva Santé Animale Main Business
Table 96. Ceva Santé Animale Latest Developments
Table 97. Chengdu TECBOND Biological Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offered
Table 99. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Chengdu TECBOND Biological Main Business
Table 101. Chengdu TECBOND Biological Latest Developments
Table 102. Institute of Animal Health and Veterinary Biologicals Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offered
Table 104. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Institute of Animal Health and Veterinary Biologicals Main Business
Table 106. Institute of Animal Health and Veterinary Biologicals Latest Developments
Table 107. Institute of Veterinary Preventive Medicine Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offered
Table 109. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Institute of Veterinary Preventive Medicine Main Business
Table 111. Institute of Veterinary Preventive Medicine Latest Developments
Table 112. International Duck Research Cooperative Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offered
Table 114. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. International Duck Research Cooperative Main Business
Table 116. International Duck Research Cooperative Latest Developments
Table 117. MSD Animal Health (Merck) Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offered
Table 119. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. MSD Animal Health (Merck) Main Business
Table 121. MSD Animal Health (Merck) Latest Developments
Table 122. Ringpu (Tianjin)Bio-Pharmacy Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offered
Table 124. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Ringpu (Tianjin)Bio-Pharmacy Main Business
Table 126. Ringpu (Tianjin)Bio-Pharmacy Latest Developments
Table 127. Veterinary Research Institute Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offered
Table 129. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Veterinary Research Institute Main Business
Table 131. Veterinary Research Institute Latest Developments
List of Figures
Figure 1. Picture of Duck Virus Enteritis Vaccine
Figure 2. Duck Virus Enteritis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Duck Virus Enteritis Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Duck Virus Enteritis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Duck Virus Enteritis Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Duck Virus Enteritis Vaccine Sales Market Share by Type in 2021
Figure 12. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Duck Virus Enteritis Vaccine Consumed in Duck
Figure 14. Global Duck Virus Enteritis Vaccine Market: Duck (2017-2022) & (K Units)
Figure 15. Duck Virus Enteritis Vaccine Consumed in Others
Figure 16. Global Duck Virus Enteritis Vaccine Market: Others (2017-2022) & (K Units)
Figure 17. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application in 2021
Figure 19. Duck Virus Enteritis Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Duck Virus Enteritis Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Duck Virus Enteritis Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Duck Virus Enteritis Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Duck Virus Enteritis Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Duck Virus Enteritis Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Duck Virus Enteritis Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Duck Virus Enteritis Vaccine
Figure 63. Industry Chain Structure of Duck Virus Enteritis Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...